Graphic version of this page | Change how these pages look
Home←Clinical support←Formulary←Ruxolitinib (Jakavi®)
Ruxolitinib (Jakavi®)
- Traffic Light
Red
- BNF
8.1.5
- Licensed Indicators
Myelofibrosis, either primary in origin or following other related disorders such as polycythaemia
- Reference
APC Dec 12
- Criteria
- Provisional
Yes
Do you want to add this to your CPD record?
Did you find this page helpful?
© 2024
Website by Sitekit, body system icons designed by Freepik